(Q30327961)

18 June 2017

1 reference

title

Recommendations for the management of behavioral and psychological symptoms of dementia. (English)

1 reference

18 June 2017

Herrmann N

1

1 reference

18 June 2017

language of work or name

1 reference

1 February 2001

1 reference

Canadian Journal of Neurological Sciences

18 June 2017

published in

1 reference

18 June 2017

volume

28 Suppl 1

1 reference

18 June 2017

page(s)

S96-107

1 reference

Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5-HT3 receptor antagonist

18 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

The relationship between vision impairment and the assessment of disruptive behaviors among nursing home residents

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Leuprolide acetate for exhibitionism in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Assessing the clinical effectiveness of preventive maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian Task Force on the Periodic Health Examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

The relationship between donepezil and behavioral disturbances in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Physostigmine ameliorates the delusions of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

The spectrum of behavioral changes in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Assessment of cognitive, psychiatric, and behavioral disturbances in patients with dementia: the Neurobehavioral Rating Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Troublesome and disruptive behaviors in dementia. Relationships to diagnosis and disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Behavioral problems among patients in skilled nursing facilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Cholinesterase inhibitors: A new class of psychotropic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Buspirone vs. Haloperidol: A Double-Blind Trial for Agitation in a Nursing Home Population With Alzheimer's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Dementia: the experience of family caregivers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Lewy body dementia--diagnosis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Psychiatric phenomena in Alzheimer's disease. IV: Disorders of behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Overview of depression and psychosis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Effects of Buspirone on Agitation Associated With Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Behavioral disturbance in dementia of the Alzheimer's type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

The psychiatric symptoms of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Alleviating agitation, apprehension, and related symptoms in geriatric patients: A double-blind comparison of a phenothiazine and a benzodiazepien

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Comparison of Thioridazine and Diazepam in the Control of Nonpsychotic Symptoms Associated with Senility: Double-Blind Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Nonneuroleptic treatment of disruptive behavior in organic mental syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Treatment of behavioral problems with pindolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Gabapentin for behavioral agitation in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Valproic acid treatment of agitation in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Valproate treatment of older psychotic patients with organic mental syndromes and behavioral dyscontrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

The effects of sodium valproate on disturbed behavior in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Efficacy and tolerability of carbamazepine for agitation and aggression in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

A preliminary study of carbamazepine in the treatment of assaultive patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Carbamazepine treatment of agitation associated with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Neuroleptic sensitivity in patients with senile dementia of Lewy body type

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

L-deprenyl in Alzheimer's disease: cognitive and behavioral effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

L-deprenyl in the treatment of mild dementia of the Alzheimer type: results of a 15-month trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Effects of a MAO-B inhibitor in the treatment of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Brief information on an early phase-II study with deprenyl in demented patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

21 January 2018

Frontotemporal Dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

The course of psychopathologic features in mild to moderate Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Effects of antipsychotic withdrawal in elderly nursing home residents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Delirium in the elderly patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Recent advances in geriatric psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Effect of the Omnibus Reconciliation Act 1987 on antipsychotic prescribing in nursing home residents

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

A naturalistic study of trazodone in the treatment of behavioral complications of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Use of psychoactive medication and the quality of care in rest homes. Findings and policy implications of a statewide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Behavioral analysis and nursing interventions for reducing disruptive behaviors of patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Behavioural disturbances in the demented elderly: phenomenology, pharmacotherapy and behavioural management

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Dinner music for demented patients: analysis of video-recorded observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Effects of relaxing music on agitation during meals among nursing home residents with severe cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

The effect of music on repetitive disruptive vocalizations of persons with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

A randomized trial of dementia care in nursing homes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Modifying repetitive verbalizations of community-dwelling patients with AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

The efficacy of psychosocial approaches to behaviour disorders in dementia: a systematic literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Aggressive behavior in hospitalized psychogeriatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Agitated behaviors in the elderly. II. Preliminary results in the cognitively deteriorated

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Agitated behaviors in the elderly. I. A conceptual review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

Gabapentin for disruptive behaviour in an elderly demented patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Treatment of dementia with behavioral disturbance using divalproex or a combination of divalproex and a neuroleptic.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Leuprolide treatment of sexual aggression in a patient with Dementia and the Klüver-Bucy syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Safety and effectiveness of low-dose clozapine in psychogeriatric patients: a preliminary study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Treatment of dementia-associated agitation with gabapentin

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Carbamazepine treatment of agitation in nursing home patients with dementia: a preliminary study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Clonazepam for agitated patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Trazodone for Behavioral Disturbance in Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Neuroleptic-Induced Parkinsonism in Elderly Patients Diagnosed With Psychotic Major Depression and Dementia of the Alzheimer Type

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Donepezil for behavioural disorders associated with Lewy bodies: a case series

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Propranolol treatment of assaultive patients with organic brain disease. A double-blind crossover, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Pharmacologic treatment of noncognitive symptoms of dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Environmental "white noise": an intervention for verbally agitated nursing home residents

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Olanzapine use in the elderly: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Ondansetron for hallucinosis in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Efficacy and safety of neuroleptics in behavioral disorders associated with dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Interventions for the behavioral complications of Alzheimer's disease: behavioral approaches

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Effects of individualized music on confused and agitated elderly patients

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Neuropsychiatric aspects of multi-infarct dementia and dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Staff observation aggression scale, SOAS: presentation and evaluation

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Psychiatric phenomena in Alzheimer's disease. I: Disorders of thought content

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Tardive dyskinesia: a review.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Management of behavior disturbance in Alzheimer disease: current knowledge and future directions.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Disruptive behavior in elderly nursing home residents: a survey of nursing staff

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Effects of environmental stimulation on biochemical and psychological variables in dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Propranolol in organic agitation

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Carbamazepine for assaultive patients with organic brain disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Improving medication prescribing and utilization in the nursing home

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

The Use of Estrogen to Decrease Aggressive Physical Behavior in Elderly Men with Dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Effectiveness of gabapentin for the treatment of behavioral disorders in dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Unnecessary Use of Tranquillizers in Elderly Patients

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Discontinuation of Antipsychotics in Nursing Home Patients With Dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Fluvoxamine in the treatment of demented elderly patients: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

ECT: an effective treatment in the screaming demented patient

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Psychiatric phenomena in Alzheimer's disease. II: Disorders of perception

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

A reduced stimulation unit: effects on patients with Alzheimer's disease and related disorders

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Psychiatric phenomena in Alzheimer's disease. III: Disorders of mood

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Risperidone for dementia-related disturbed behavior in nursing home residents: a clinical experience

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Delirium and dementia: diagnostic criteria and fatality rates

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Gabapentin for the management of agitation

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

Application of operant procedures in a group of institutionalized aggressive geriatric patients

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001268

7 January 2021

10.1017/S0317167100001268

Identifiers

DOI

1 reference

18 June 2017

1 reference